Related references
Note: Only part of the references are listed.Polymer-stabilized Cas9 nanoparticles and modified repair templates increase genome editing efficiency
David N. Nguyen et al.
NATURE BIOTECHNOLOGY (2020)
Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors
Enli Liu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Synthesis and mechanistic investigations of pH-responsive cationic poly(aminoester)s
Timothy R. Blake et al.
CHEMICAL SCIENCE (2020)
Reversible RNA acylation for control of CRISPR-Cas9 gene editing
Maryam Habibian et al.
CHEMICAL SCIENCE (2020)
Local Delivery of Ox40l, Cd80, and Cd86 mRNA Kindles Global Anticancer Immunity
Ole Audun Werner Haabeth et al.
CANCER RESEARCH (2019)
Oligo(serine ester) Charge-Altering Releasable Transporters: Organocatalytic Ring-Opening Polymerization and their Use for in Vitro and in Vivo mRNA Delivery
Nancy L. Benner et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2019)
Adoptive cell therapy using engineered natural killer cells
Katayoun Rezvani
BONE MARROW TRANSPLANTATION (2019)
Engineered amphiphilic peptides enable delivery of proteins and CRISPR-associated nucleases to airway epithelia
Sateesh Krishnamurthy et al.
NATURE COMMUNICATIONS (2019)
A Microfluidic Device to Enhance Viral Transduction Efficiency During Manufacture of Engineered Cellular Therapies
Nathan Moore et al.
SCIENTIFIC REPORTS (2019)
CAR-Engineered NK Cells for the Treatment of Glioblastoma: Turning Innate Effectors Into Precision Tools for Cancer Immunotherapy
Michael C. Burger et al.
FRONTIERS IN IMMUNOLOGY (2019)
NK Cell-Based Immunotherapy for Hematological Malignancies
Simona Sivori et al.
JOURNAL OF CLINICAL MEDICINE (2019)
CAR-Expressing Natural Killer Cells for Cancer Retargeting
Stephan Kloess et al.
TRANSFUSION MEDICINE AND HEMOTHERAPY (2019)
Cord blood NK cells engineered to express IL-15 and a CD19-targeted CAR show long-term persistence and potent antitumor activity
E. Liu et al.
LEUKEMIA (2018)
Functional DNA Delivery Enabled by Lipid-Modified Charge-Altering Releasable Transporters (CARTs)
Nancy L. Benner et al.
BIOMACROMOLECULES (2018)
Diversification of human NK cells: Lessons from deep profiling
Aaron J. Wilk et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2018)
Reducing the Cytotoxicity of Lipid Nanoparticles Associated with a Fusogenic Cationic Lipid in a Natural Killer Cell Line by Introducing a Polycation-Based siRNA Core
Takashi Nakamura et al.
MOLECULAR PHARMACEUTICS (2018)
Membrane permeabilizing amphiphilic peptide delivers recombinant transcription factor and CRISPR-Cas9/Cpf1 ribonucleoproteins in hard-to-modify cells
Thomas Del Guidice et al.
PLOS ONE (2018)
Enhanced mRNA delivery into lymphocytes enabled by lipid-varied libraries of charge-altering releasable transporters
Colin J. McKinlay et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Intrinsic Functional Potential of NK-Cell Subsets Constrains Retargeting Driven by Chimeric Antigen Receptors
Vincent Yi Sheng Oei et al.
CANCER IMMUNOLOGY RESEARCH (2018)
Allergic inflammatory memory in human respiratory epithelial progenitor cells
Jose Ordovas-Montanes et al.
NATURE (2018)
mRNA vaccination with charge-altering releasable transporters elicits human T cell responses and cures established tumors in mice
Ole A. W. Haabeth et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Purinergic targeting enhances immunotherapy of CD73(+) solid tumors with piggyBac-engineered chimeric antigen receptor natural killer cells
Jiao Wang et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Marker-free coselection for CRISPR-driven genome editing in human cells
Daniel Agudelo et al.
NATURE METHODS (2017)
In situ programming of leukaemia-specific T cells using synthetic DNA nanocarriers
Tyrel T. Smith et al.
NATURE NANOTECHNOLOGY (2017)
Influence of nanoparticle-mediated transfection on proliferation of primary immune cells in vitro and in vivo
Susanne Przybylski et al.
PLOS ONE (2017)
Charge-altering releasable transporters (CARTs) for the delivery and release of mRNA in living animals
Colin J. McKinlay et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Mass Cytometry Analytical Approaches Reveal Cytokine-Induced Changes in Natural Killer Cells
Elena Vendrame et al.
CYTOMETRY PART B-CLINICAL CYTOMETRY (2017)
Small-sized, stable lipid nanoparticle for the efficient delivery of siRNA to human immune cell lines
Takashi Nakamura et al.
SCIENTIFIC REPORTS (2016)
Natural killer cell memory in infection, inflammation and cancer
Adelheid Cerwenka et al.
NATURE REVIEWS IMMUNOLOGY (2016)
4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptors
Adrienne H. Long et al.
NATURE MEDICINE (2015)
Human NK cell repertoire diversity reflects immune experience and correlates with viral susceptibility
Dara M. Strauss-Albee et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Advantages and applications of CAR-expressing natural killer cells
Wolfgang Glienke et al.
FRONTIERS IN PHARMACOLOGY (2015)
Genetic manipulation of NK cells for cancer immunotherapy: techniques and clinical implications
Mattias Carlsten et al.
FRONTIERS IN IMMUNOLOGY (2015)
Improving the safety of cell therapy products by suicide gene transfer
Benjamin S. Jones et al.
Frontiers in Pharmacology (2014)
Genetic and Environmental Determinants of Human NK Cell Diversity Revealed by Mass Cytometry
Amir Horowitz et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Neuraminidase-Mediated, NKp46-Dependent Immune-Evasion Mechanism of Influenza Viruses
Yotam Bar-On et al.
CELL REPORTS (2013)
Polycation-based nanoparticle delivery of RNAi therapeutics: Adverse effects and solutions
Borja Ballarin-Gonzalez et al.
ADVANCED DRUG DELIVERY REVIEWS (2012)
A clinically adaptable method to enhance the cytotoxicity of natural killer cells against B-cell malignancies
Noriko Shimasaki et al.
CYTOTHERAPY (2012)
Inhibition of Intracellular Antiviral Defense Mechanisms Augments Lentiviral Transduction of Human Natural Killer Cells: Implications for Gene Therapy
Tolga Sutlu et al.
HUMAN GENE THERAPY (2012)
Transfecting the hard-to-transfect lymphoma/leukemia cells using a simple cationic polymer nanocomplex
Nianxi Zhao et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Comparison of mRNA and lentiviral based transfection of natural killer cells with chimeric antigen receptors recognizing lymphoid antigens
Laurent Boissel et al.
LEUKEMIA & LYMPHOMA (2012)
Tuning of Natural Killer Cell Reactivity by NKp46 and Helios Calibrates T Cell Responses
Emilie Narni-Mancinelli et al.
SCIENCE (2012)
Treatment of Advanced Leukemia in Mice with mRNA Engineered T Cells
David M. Barrett et al.
HUMAN GENE THERAPY (2011)
Regulation of human NK-cell cytokine and chemokine production by target cell recognition
Cyril Fauriat et al.
BLOOD (2010)
Expression of chimeric antigen receptors in natural killer cells with a regulatory-compliant non-viral method
L. Li et al.
CANCER GENE THERAPY (2010)
NKp46 O-Glycan Sequences That Are Involved in the Interaction with Hemagglutinin Type 1 of Influenza Virus
Michal Mendelson et al.
JOURNAL OF VIROLOGY (2010)
Expansion of Highly Cytotoxic Human Natural Killer Cells for Cancer Cell Therapy
Hiroyuki Fujisaki et al.
CANCER RESEARCH (2009)
Permanent silencing of NKG2A expression for cell-based therapeutics
Constanca Figueiredo et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2009)
Transfection with mRNA for CD19 specific chimeric antigen receptor restores NK cell mediated killing of CLL cells
Laurent Boissel et al.
LEUKEMIA RESEARCH (2009)
High-efficient lentiviral vector-mediated gene transfer into primary human NK cells
Federica Micucci et al.
EXPERIMENTAL HEMATOLOGY (2006)
Toxicity of cationic lipids and cationic polymers in gene delivery
Hongtao Lv et al.
JOURNAL OF CONTROLLED RELEASE (2006)
Lethal influenza infection in the absence of the natural killer cell receptor gene Ncr1
R Gazit et al.
NATURE IMMUNOLOGY (2006)
Efficient infection of human natural killer cells with an EBV/retroviral hybrid vector
B Becknell et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2005)
Efficient gene transfer into the human natural killer cell line, NKL, using the Amaxa nucleofection system (TM)
K Maasho et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2004)
Share Paper
